As of Aug 26
| -0.0005 / -0.15%|
The 3 analysts offering 12-month price forecasts for Apricus Biosciences Inc have a median target of 1.00, with a high estimate of 1.25 and a low estimate of 0.50. The median estimate represents a +194.12% increase from the last price of 0.34.
The current consensus among 3 polled investment analysts is to Buy stock in Apricus Biosciences Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.